Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Kaylin V. Dance, Conner B. Imbody, Lillian Chen, Lorna McNeill, Jackelyn B. Payne & Christopher R. Flowers. (2021) Perceptions of clinical care and research among African-American patients with lymphoma. Leukemia & Lymphoma 62:8, pages 1860-1868.
Read now
Read now
Allison A. Petrilla, Anne Shah, Joseph Feliciano, Joseph Woolery & Thomas W. LeBlanc. (2021) Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting. Current Medical Research and Opinion 37:7, pages 1189-1197.
Read now
Read now
Nada Ahmed & Andrew L. Feldman. (2020) Targeting epigenetic regulators in the treatment of T-cell lymphoma. Expert Review of Hematology 13:2, pages 127-139.
Read now
Read now
Shunan Qi, Joachim Yahalom, Meier Hsu, Monica Chelius, Matthew Lunning, Alison Moskowitz & Steven Horwitz. (2016) Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population. Leukemia & Lymphoma 57:11, pages 2575-2583.
Read now
Read now
Qiushi Chen, Turgay Ayer, Loretta J. Nastoupil, Jean L. Koff, Ashley D. Staton, Jagpreet Chhatwal & Christopher R. Flowers. (2016) Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:4, pages 842-851.
Read now
Read now
Jianliang Yang, Yuankai Shi, Xiaohui He, Mei Dong, Changgong Zhang, Peng Liu, Shengyu Zhou, Yan Qin, Lin Gui, Sheng Yang & Yan Sun. (2015) A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma. Leukemia & Lymphoma 56:7, pages 2218-2221.
Read now
Read now
Dai Chihara, Loretta J Nastoupil, Jessica N Williams, Paul Lee, Jean L Koff & Christopher R Flowers. (2015) New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Review of Anticancer Therapy 15:5, pages 531-544.
Read now
Read now
Gregory B. Kruse, Michele H. Potashman, Spyros Stavrakas & Bruce J. Wong. (2014) Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma. Journal of Medical Economics 17:7, pages 446-458.
Read now
Read now
Li Jiang, Shao-Jun Li, Yue-Ming Jiang, Jian-Xiong Long, Ren-Sheng Wang, Jing Su & Yong Zhang. (2014) The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis. Leukemia & Lymphoma 55:5, pages 1038-1048.
Read now
Read now
Roopesh Kansara & Kerry J. Savage. (2014) The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma. Leukemia & Lymphoma 55:4, pages 727-729.
Read now
Read now
Francine M. Foss, Nelida Sjak-Shie, Andre Goy, Eric Jacobsen, Ranjana Advani, Mitchell R. Smith, Rami Komrokji, Kelly Pendergrass & Vanessa Bolejack. (2013) A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study. Leukemia & Lymphoma 54:7, pages 1373-1379.
Read now
Read now
Muhammad Hassaan Imam, Pareen J. Shenoy, Christopher R. Flowers, Adrienne Phillips & Mary Jo Lechowicz. (2013) Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leukemia & Lymphoma 54:4, pages 752-759.
Read now
Read now
Alexei Shimanovsky & Constantin A Dasanu. (2013)
Pralatrexate: evaluation of clinical efficacy and toxicity in T-cell lymphoma. Expert Opinion on Pharmacotherapy 14:4, pages 515-523.
Read now
Read now
Rajni Sinha, Loretta J Nastoupil & Christopher R Flowers. (2012) Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 87-98.
Read now
Read now
Adrienne A Phillips, Colette Owens, Sangmin Lee & Govind Bhagat. (2011) An update on the management of peripheral T-cell lymphoma and emerging treatment options. Journal of Blood Medicine 2, pages 119-129.
Read now
Read now
Anamarija M. Perry, Hernan Molina-Kirsch, Bharat N. Nathwani, Jacques Diebold, kenneth A. Maclennan, H. Konrad Müller-Hermelink, James O. Armitage & Dennis D. Weisenburger. (2011) Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system. Leukemia & Lymphoma 52:9, pages 1681-1688.
Read now
Read now
Abeer N Abouyabis, Pareen J Shenoy, Mary Jo Lechowicz & Christopher R Flowers. (2011) Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas. Expert Opinion on Biological Therapy 11:1, pages 31-40.
Read now
Read now
Holbrook Kohrt, Mark Lee & Ranjana Advani. (2010) Risk stratification in extranodal natural killer/T-cell lymphoma. Expert Review of Anticancer Therapy 10:9, pages 1395-1405.
Read now
Read now
Andrei R. Shustov. (2008) T-cell lymphoma – one name with a dozen faces. Leukemia & Lymphoma 49:11, pages 2033-2034.
Read now
Read now
Articles from other publishers (96)
Rahul M. DhodapkarJane Z. SpadaroJacob S. HengJohn H. SinardYan Ho LeeLarissa A. HabibRenelle Pointdujour-Lim. (2023) NK/T-cell Lymphoma With Orbital Involvement: A Case Report and Systematic Review of the Literature. Ophthalmic Plastic & Reconstructive Surgery 39:4, pages 316-327.
Crossref
Crossref
John M BurkeKristina S YuUche MordiBrian BloudekNicholas LiuTycel Phillips. (2023) Estimating long-term progression-free and overall survival in patients with peripheral T-cell lymphoma: A US population-based oncology simulation model based on 5-year results from the ECHELON-2 trial. Journal of Managed Care & Specialty Pharmacy 29:3, pages 314-323.
Crossref
Crossref
Rafael Henriques Figueiredo, Beatriz Simao Parreira & Pedro Amoroso Canao. (2022) Peripheral T-Cell Lymphoma, Not Otherwise Specified – a case report and short literature review. Archive of Clinical Cases 9:4, pages 140-144.
Crossref
Crossref
Margaret Ann Kreher, John Ahn, Tyler Werbel & Kiran Motaparthi. (2022) Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination. JAAD Case Reports 28, pages 18-20.
Crossref
Crossref
Binyao Chen, Shizhao Yang & Wenru Su. (2022) First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review. BMC Ophthalmology 22:1.
Crossref
Crossref
Lingling Xu, Xianqi Liu, Yan Wang, Yanming Wang, Xiaoxia Chu & Liming Chen. (2022) Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis. Medicine 101:9, pages e28943.
Crossref
Crossref
Kamal Bandhu Klanidhi, S. Ashwin Monian & Avinash Chakrawarty. (2021) Acral vascular syndrome Lennert type T cell lymphoma—a case report. Journal of the Egyptian National Cancer Institute 33:1.
Crossref
Crossref
Sotaro Ozaka, Kunimitsu Inoue, Tomoya Okajima, Takako Tasaki, Shimpei Ariki, Hideki Ono, Takeaki Ando, Tsutomu Daa & Kazunari Murakami. (2021) Monomorphic epitheliotropic intestinal T-cell lymphoma presenting as melena with long-term survival: A case report and review of literature. World Journal of Gastroenterology 27:38, pages 6501-6510.
Crossref
Crossref
Jasmine M. Zain & Paul Hanona. (2021) Aggressive T‐cell lymphomas: 2021 Updates on diagnosis, risk stratification and management. American Journal of Hematology 96:8, pages 1027-1046.
Crossref
Crossref
Amulya Yellala, Avyakta Kallam & James O. Armitage. 2021. The Peripheral T‐Cell Lymphomas. The Peripheral T‐Cell Lymphomas
57
68
.
Imran Nizamuddin, Carlos Galvez & Barbara Pro. (2021) Management of ALCL and other CD30+ peripheral T-cell lymphomas with a focus on Brentuximab vedotin. Seminars in Hematology 58:2, pages 85-94.
Crossref
Crossref
Kip E. Guja, Ryanne Brown, Brad Girod, Hong Song, Caitlyn Harrison, Benjamin L. Franc, Farshad Moradi, Guido Davidzon, Andrei Iagaru & Carina Mari Aparici. (2020) An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 48:4, pages 1256-1257.
Crossref
Crossref
Gerald G. Wulf, Bettina Altmann, Marita Ziepert, Francesco D’Amore, Gerhard Held, Richard Greil, Olivier Tournilhac, Thomas Relander, Andreas Viardot, Martin Wilhelm, Christian Wilhelm, Antonio Pezzutto, Josee M. Zijlstra, Eric Van Den Neste, Pieternella J. Lugtenburg, Jeanette K. Doorduijn, Michel van Gelder, Gustaaf W. van Imhoff, Florian Zettl, Friederike Braulke, Maike Nickelsen, Bertram Glass, Andreas Rosenwald, Philippe Gaulard, Markus Loeffler, Michael Pfreundschuh, Norbert Schmitz & Lorenz Trümper. (2020) Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial. Leukemia 35:1, pages 143-155.
Crossref
Crossref
Anne Shah, Allison Petrilla, Mayvis Rebeira, Joseph Feliciano, Julie Lisano & Thomas W. LeBlanc. (2021) Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis. Clinical Lymphoma Myeloma and Leukemia 21:1, pages e1-e9.
Crossref
Crossref
Anoshia Afzal, Azadeh Esmaeili, Sami Ibrahimi, Umar Farooque & Bradley Gehrs. (2020) Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma With Extraintestinal Areas of Peripheral T-Cell Lymphoma Involvement. Cureus.
Crossref
Crossref
Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren Pinter-Brown, Yasuhiro Oki, Prajak J. Barde, Ajit Nair, Kasi Viswanath Routhu, Srikant Viswanadha, Swaroop Vakkalanka & Swaminathan P. Iyer. (2020) Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Cancers 12:8, pages 2293.
Crossref
Crossref
Mohamed Gomaa Kamel, Amr Ehab El-Qushayri, Ahmed Kamal Sayed & Nguyen Tien Huy. (2020) Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study. Journal of Comparative Effectiveness Research 9:12, pages 861-876.
Crossref
Crossref
Wei Zhang, Jing Ruan, Daobin Zhou, Xiao Han, Yan Zhang, Wei Wang & Mingqi Ouyang. (2020) Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio. Scientific Reports 10:1.
Crossref
Crossref
Eric D. Shah, Elliot S. Coburn, Anil Nayyar, Kerry Jo Lee, Jenna L. Koliani‐Pace & Corey A. Siegel. (2020) Systematic review: hepatosplenic T‐cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System. Alimentary Pharmacology & Therapeutics 51:5, pages 527-533.
Crossref
Crossref
Enrica Marchi & Owen A. O’Connor. (2019) The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management. CA: A Cancer Journal for Clinicians 70:1, pages 47-70.
Crossref
Crossref
Yuanyuan Sun, Ling Li, Xin Li, Lei Zhang, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Zhaoming Li, Jingjing Wu, Hui Yu, Yu Chang, Jiaqin Yan, Xiaolong Wu, Zhiyuan Zhou, Feifei Nan, Li Tian & Mingzhi Zhang. (2020)
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide)
versus
CHOP in newly diagnosed peripheral T-cell lymphoma patients
. Therapeutic Advances in Medical Oncology 12, pages 175883592092382.
Crossref
Crossref
Stefan K. BartaJerald Z. Gong & Pierluigi Porcu. (2019) Brentuximab vedotin in the treatment of CD30+ PTCL. Blood 134:26, pages 2339-2345.
Crossref
Crossref
Jasmine M. Zain. (2019) Aggressive T‐cell lymphomas: 2019 updates on diagnosis, risk stratification, and management. American Journal of Hematology 94:8, pages 929-946.
Crossref
Crossref
Ana C. Xavier & Ritsuro Suzuki. (2019) Treatment and prognosis of mature (non‐anaplastic) T‐ and NK‐cell lymphomas in childhood, adolescents, and young adults. British Journal of Haematology 185:6, pages 1086-1098.
Crossref
Crossref
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2019. Bone Marrow Pathology. Bone Marrow Pathology
346
486
.
Timothy Fenske & Jonathan T. Kapke. 2019. Concise Guide to Hematology. Concise Guide to Hematology
387
399
.
Jian-Jun Ding, Ya-Lian Chen, Shui-Hong Zhou & Kui Zhao. (2018) Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma. Journal of International Medical Research 46:12, pages 4920-4929.
Crossref
Crossref
Yi-Jiun Su, Po-Nan Wang, Hung Chang, Lee-Yung Shih, Tung-Liang Lin, Ming-Chung Kuo, Wen-Yu Chuang, Jin-Hou Wu, Tzung-Chih Tang, Yu-Shin Hung, Po Dunn & Hsiao-Wen Kao. (2018) Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases. European Journal of Haematology 101:3, pages 379-388.
Crossref
Crossref
Aditi Jani, Matthew Innes, Vishnu Reddy, Carlos N. Prieto-Granada, Lauren V. Graham & Elizabeth N. Ergen. (2018) Peripheral T-cell lymphoma, not otherwise specified, presenting with generalized ulcerated plaques and hypereosinophilia. JAAD Case Reports 4:7, pages 651-654.
Crossref
Crossref
Norbert Schmitz, Georg Lenz & Matthias Stelljes. (2018) Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas. Blood 132:3, pages 245-253.
Crossref
Crossref
Mengxuan Zuo, Haorui Shen, Jingjing Yin, Wei Wang, Yan Zhang, Dao-Bin Zhou & Wei Zhang. (2018) Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma. Leukemia Research 70, pages 56-61.
Crossref
Crossref
Andrew L. Feldman & Christopher R. Flowers. (2018)
Ethnic disparity in primary cutaneous
CD
30
+
T‐cell lymphoproliferative disorders: an analysis of 1496 cases from the
US
National Cancer database
. British Journal of Haematology 181:6, pages 721-722.
Crossref
Crossref
Loretta J. Nastoupil, Jean L. Koff, Leon Bernal‐Mizrachi & Christopher R. Flowers. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice
444
462
.
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
435
480
.
Jennifer E. Amengual, Renee LichtensteinJennifer LueAhmed SawasChangchun DengEmily LichtensteinKaren KhanLaine AtkinsAishling RadaHye A. KimCodruta Chiuzan, Matko KalacEnrica MarchiLorenzo FalchiMark A. Francescone, Lawrence Schwartz, Serge Cremers & Owen A. O’Connor. (2018) A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. Blood 131:4, pages 397-407.
Crossref
Crossref
Shawn Karls, Hina Shah & Heather Jacene. (2018) PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Seminars in Nuclear Medicine 48:1, pages 37-49.
Crossref
Crossref
Jonathan E. Brammer, Dai Chihara, L. Michelle Poon, Paolo Caimi, Marcos de Lima, Celina Ledesma, Gabriela Rondon, Stefan O. Ciurea, Yago Nieto, Michelle Fanale, Bouthaina Dabaja, Richard T. Maziarz, Richard E. Champlin, Chitra Hosing & Yasuhiro Oki. (2018) Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes. Clinical Lymphoma Myeloma and Leukemia 18:1, pages e41-e50.
Crossref
Crossref
A. Ruple, A. C. Avery & P. S. Morley. (2017) Differences in the geographic distribution of lymphoma subtypes in Golden retrievers in the USA. Veterinary and Comparative Oncology 15:4, pages 1590-1597.
Crossref
Crossref
Monica Bellei, Elena Sabattini, Emanuela Anna Pesce, Young-Hyeh Ko, Won Seog Kim, Maria Elena Cabrera, Virginia Martinez, Ivan Dlouhy, Roberto Pinto Paes, Tomas Barrese, Josè Vassallo, Vittoria Tarantino, Julie Vose, Dennis Weisenburger, Thomas Rüdiger, Massimo Federico & Stefano Pileri. (2017) Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematological Oncology 35:4, pages 630-636.
Crossref
Crossref
Tatyana Feldman, Charles M. Farber, Kelly Choi, Claudio Faria, Andre Goy, Jacqueline Connors, Dhakshila Paramanathan, Sukhi Kaur, Eric Schultz, Michael McGuire & Stuart L. Goldberg. (2017) Treatment of Peripheral T-Cell Lymphoma in Community Settings. Clinical Lymphoma Myeloma and Leukemia 17:6, pages 354-361.
Crossref
Crossref
Yuhei Shibata, Takeshi Hara, Senji Kasahara, Toshiki Yamada, Michio Sawada, Ryoko Mabuchi, Takuro Matsumoto, Nobuhiko Nakamura, Hiroshi Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Nobuhiro Kanemura, Yusuke Kito, Naoe Goto, Tatsuhiko Miyazaki, Tsuyoshi Takami, Tamotsu Takeuchi, Masahito Shimizu & Hisashi Tsurumi. (2015) CHOP or THP‐COP regimens in the treatment of newly diagnosed peripheral T‐cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin. Hematological Oncology 35:2, pages 163-171.
Crossref
Crossref
Guru Subramanian Guru Murthy, Mehdi Hamadani, Vijaya Raj Bhatt, Ishwori Dhakal & Paulette Mehta. (2017) Systemic Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma: A Population-based Analysis of Incidence and Survival. Clinical Lymphoma Myeloma and Leukemia 17:4, pages 201-206.
Crossref
Crossref
Xiao Han, Wei Zhang, Daobin Zhou, Jing Ruan, Minghui Duan, Tienan Zhu, Jian Li, Huacong Cai, Xinxin Cao & Mingqi Ouyang. (2017) Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience. Journal of International Medical Research 45:1, pages 290-302.
Crossref
Crossref
Hye Sun ParkLacey McIntoshMarta Braschi-AmirfarzanAtul B. ShinagareKatherine M. Krajewski. (2017) T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean Journal of Radiology 18:1, pages 71.
Crossref
Crossref
Bowei Tan, Cherif Abdelmalek, James E. O\'Donnell, Thomas Toltaku, Rashid Chaudhry, Jen C. Wang & Vladimir Gotlieb. (2017) A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome. American Journal of Case Reports 18, pages 160-165.
Crossref
Crossref
Masooma Aqeel, Bjorn Batdorf, Horatiu Olteanu & Jayshil J. Patel. (2017) An Unusual Suspect Causing Hypoxemic Respiratory Failure. Journal of Investigative Medicine High Impact Case Reports 5:1, pages 232470961668758.
Crossref
Crossref
Jasmine Zain. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach
173
201
.
Emilie Reboursiere, Fabien Le Bras, Charles Herbaux, Emmanuel Gyan, Aline Clavert, Franck Morschhauser, Sandra Malak, David Sibon, Florence Broussais, Thorsten Braun, Luc-Matthieu Fornecker, Reda Garidi, Sabine Tricot, Roch Houot, Bertrand Joly, Wajed Abarah, Bachra Choufi, Anne-Dominique Pham, Anne-Claire Gac, Christophe Fruchart, Emilie Marin, Violaine Safar, Anne Parcelier, Hervé Maisonneuve, Emmanuel Bachy, Guillaume Cartron, Arnaud Jaccard, Olivier Tournilhac, Cédric Rossi, Luciane Schirmer, Jean-Alain Martignoles, Philippe Gaulard, Hervé Tilly, Gandhi Damaj & From the Lymphoma Study Association centers. (2016) Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget 7:51.
Crossref
Crossref
Bradley M. Haverkos, Zenggang Pan, Alejandro A. Gru, Aharon G. Freud, Rachel Rabinovitch, Meng Xu-Welliver, Brad Otto, Carlos Barrionuevo, Robert A. Baiocchi, Rosemary Rochford & Pierluigi Porcu. (2016) Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases. Current Hematologic Malignancy Reports 11:6, pages 514-527.
Crossref
Crossref
Rebecca L. BoddickerGina L. Razidlo, Surendra DasariYu ZengGuangzhen HuRyan A. KnudsonPatricia T. GreippJaime I. DavilaSarah H. JohnsonJulie C. PorcherJames B. SmadbeckBruce W. EckloffDaniel D. Billadeau, Paul J. KurtinMark A. McNiven, Brian K. LinkStephen M. Ansell, James R. Cerhan, Yan W. Asmann, George VasmatzisAndrew L. Feldman. (2016) Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. Blood 128:9, pages 1234-1245.
Crossref
Crossref
Vinodh Pillai, Michael Tallarico, Michael R. Bishop & Megan S. Lim. (2016) Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents. British Journal of Haematology 173:4, pages 573-581.
Crossref
Crossref
Scott V. AdamsPolly A. NewcombAndrei R. Shustov. (2016) Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States. Journal of Clinical Oncology 34:9, pages 963-971.
Crossref
Crossref
HUA-PING DU, QIAN-QIAN YANG & YE ZHANG. (2016) Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: A case report and review of the literature. Oncology Letters 11:3, pages 2310-2314.
Crossref
Crossref
Xianfeng Liu, Yong Yang, Fu Jin, Yanan He, Mingsong Zhong, Huanli Luo, Da Qiu, Chao Li, Han Yang, Guanglei He & Ying Wang. (2016) A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma. Medical Dosimetry 41:1, pages 42-46.
Crossref
Crossref
Rena Buckstein, Graeme Fraser, Matthew Cheung, Vishal Kukreti, John Kuruvilla, Kevin Imrie, Eugenia Piliotis, Gregory Pond, Jolanta Windsor, Zeina Ghorab, Kevin Shuoprasad, Ruth Turner, Ralph M. Meyer, Kathy Pritchard, Scott Walker, Mark Levine & Michael Crump. (2016) Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study. Clinical Lymphoma Myeloma and Leukemia 16:1, pages 18-28.e4.
Crossref
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology
6-108
6-111
.
Ashley D Staton, Jean L Koff, Qiushi Chen, Turgay Ayer & Christopher R Flowers. (2015) Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncology 11:17, pages 2443-2457.
Crossref
Crossref
Jean L. Koff, Dai Chihara, Anh Phan, Loretta J. Nastoupil, Jessica N. Williams & Christopher R. Flowers. (2015) To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes. Current Hematologic Malignancy Reports 10:3, pages 244-255.
Crossref
Crossref
Ranjit Kumar Chaudhary, Vijaya Raj Bhatt & Julie M. Vose. (2015) Management of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Clinical Lymphoma Myeloma and Leukemia 15:5, pages 245-252.
Crossref
Crossref
Rajendra Gharbaran. (2015) Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies. Critical Reviews in Oncology/Hematology 94:1, pages 1-17.
Crossref
Crossref
Anna Czyż. (2015) Postępy w leczeniu agresywnych chłoniaków z obwodowych komórek T. Acta Haematologica Polonica 46:2, pages 94-99.
Crossref
Crossref
Adam M. Petrich, Irene B. Helenowski, Locke J. Bryan, Shaina A. Rozell, Robert Galamaga & Chadi Nabhan. (2015) Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era. British Journal of Haematology 168:5, pages 708-718.
Crossref
Crossref
Andrew M. Intlekofer & Anas Younes. (2014) From empiric to mechanism-based therapy for peripheral T cell lymphoma. International Journal of Hematology 99:3, pages 249-262.
Crossref
Crossref
Maria Gkotzamanidou & Christos A. Papadimitriou. (2014) Peripheral T-cell lymphoma: The role of hematopoietic stem cell transplantation. Critical Reviews in Oncology/Hematology 89:2, pages 248-261.
Crossref
Crossref
Catherine Bulka, Loretta J. Nastoupil, William McClellan, Alexander Ambinder, Adrienne Phillips, Kevin Ward, A. Rana Bayakly, Jeffrey M. Switchenko, Lance Waller & Christopher R. Flowers. (2013) Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer 119:18, pages 3309-3317.
Crossref
Crossref
Eric D Jacobsen. (2013) Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data. Clinical Investigation 3:7, pages 665-679.
Crossref
Crossref
Anna Czyz, Joanna Romejko-Jarosinska, Grzegorz Helbig, Wanda Knopinska-Posluszny, Lidia Poplawska, Beata Piatkowska-Jakubas, Dorota Hawrylecka, Barbara Nasilowska-Adamska, Dominik Dytfeld, Anna Lojko-Dankowska, Anna Kopinska, Piotr Boguradzki, Jan Walewski, Slawomira Kyrcz-Krzemien, Andrzej Hellmann & Mieczyslaw Komarnicki. (2013) Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis. Annals of Hematology 92:7, pages 925-933.
Crossref
Crossref
Alexander J. Ambinder, Pareen J. Shenoy, Loretta J. Nastoupil & Christopher R. Flowers. (2013) Using primary site as a predictor of survival in mantle cell lymphoma. Cancer 119:8, pages 1570-1577.
Crossref
Crossref
Xi‐Mei Zhang, Ye‐Xiong Li, Wei‐Hu Wang, Jing Jin, Shu‐Lian Wang, Yue‐Ping Liu, Yong‐Wen Song, Hua Ren, Hui Fang, Li‐Qiang Zhou, Bo Chen, Shu‐Nan Qi, Qing‐Feng Liu, Ning‐Ning Lu, Xin‐Fan Liu & Zi‐Hao Yu. (2013) Favorable outcome with doxorubicin‐based chemotherapy and radiotherapy for adult patients with early stage primary systemic anaplastic large‐cell lymphoma. European Journal of Haematology 90:3, pages 195-201.
Crossref
Crossref
Francine M. Foss. (2013) Treatment strategies for peripheral T-cell lymphomas. Best Practice & Research Clinical Haematology 26:1, pages 43-56.
Crossref
Crossref
NORIYOSHI IRIYAMA, HIROMICHI TAKAHASHI, YOSHIHIRO HATTA, KATSUHIRO MIURA, YUJIN KOBAYASHI, DAISUKE KURITA, YUKIO HIRABAYASHI, ATSUKO HOJO, HITOMI KODAIRA, MAI YAGI, SATOMI KISO, YOSHIHITO UCHINO, MASARU NAKAGAWA, MACHIKO KUSUDA, SUMIKO KOBAYASHI, AKIRA HORIKOSHI, YOSHIMASA KURA, TETSUO YAMAZAKI, UMIHIKO SAWADA & JIN TAKEUCHI. (2013) Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas. Oncology Reports 29:2, pages 805-811.
Crossref
Crossref
Jean Yared & Amy Kimball. (2013) The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: A review of the literature and new perspectives. Cancer Treatment Reviews 39:1, pages 51-59.
Crossref
Crossref
Pauline Brice & Catherine ThieblemontG. Damaj. 2013. Actualités thérapeutiques dans les lymphomes. Actualités thérapeutiques dans les lymphomes
137
150
.
Francine M. Foss. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
213
237
.
Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jin Seok Kim, Seong Kyu Park, Hyo Jung Kim, Jeeyun Lee, Baek-Yeol Ryoo, Young Hyeh Ko, Jooryung Huh, Woo Ick Yang, Hee Kyung Kim, Soo Kee Min, Seung-Sook Lee, In-Gu Do, Cheolwon Suh & Won Seog Kim. (2012) Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial. European Journal of Cancer 48:17, pages 3223-3231.
Crossref
Crossref
Chadi Nabhan, Michelle Byrtek, Michael D. Taylor, Jonathan W. Friedberg, James R. Cerhan, John D. Hainsworth, Thomas P. Miller, Jamie Hirata, Brian K. Link & Christopher R. Flowers. (2012) Racial differences in presentation and management of follicular non‐Hodgkin lymphoma in the United States. Cancer 118:19, pages 4842-4850.
Crossref
Crossref
John Hui, Eugene Przespo & Anjana Elefante. (2011) Pralatrexate: A novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses. Journal of Oncology Pharmacy Practice 18:2, pages 275-283.
Crossref
Crossref
Tawatchai Pongpruttipan, Sanya Sukpanichnant, Thamathorn Assanasen, Pongsak Wannakrairot, Paisarn Boonsakan, Wasana Kanoksil, Kanita Kayasut, Winyou Mitarnun, Archrob Khuhapinant, Udomsak Bunworasate, Teeraya Puavilai, Anan Bedavanija, Adriana Garcia-Herrera, Elias Campo, James R. Cook, John Choi & Steven H. Swerdlow. (2012) Extranodal NK/T-cell Lymphoma, Nasal Type, Includes Cases of Natural Killer Cell and αβ, γδ, and αβ/γδ T-cell Origin. American Journal of Surgical Pathology 36:4, pages 481-499.
Crossref
Crossref
Annabelle L. RoddKatherine VerverisTom C. Karagiannis. (2012) Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma. Clinical Medicine Insights: Oncology 6, pages CMO.S8536.
Crossref
Crossref
Kerry J. Savage. (2011) Therapies for Peripheral T-Cell Lymphomas. Hematology 2011:1, pages 515-524.
Crossref
Crossref
Chang-li Lu, Yuan Tang, Qun-pei Yang, Mi Wang, Sha Zhao, Cheng-feng Bi, Neng-gang Jiang, Wen-yan Zhang, Jian-ping Liu, Xia Xu & Wei-ping Liu. (2011) Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of17 Chinese cases. Human Pathology 42:12, pages 1965-1978.
Crossref
Crossref
Pareen J. Shenoy, Neha Malik, Rajni Sinha, Ajay Nooka, Loretta J. Nastoupil, Melody Smith & Christopher R. Flowers. (2011) Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States. Clinical Lymphoma Myeloma and Leukemia 11:6, pages 498-506.
Crossref
Crossref
K Yakimchuk, M Iravani, M S Hasni, P Rhönnstad, S Nilsson, M Jondal & S Okret. (2011) Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia 25:7, pages 1103-1110.
Crossref
Crossref
Francine Foss. (2011) Evolving therapy of peripheral T-cell lymphoma: 2010 and beyond. Therapeutic Advances in Hematology 2:3, pages 161-173.
Crossref
Crossref
Pareen J. Shenoy, Neha Malik, Ajay Nooka, Rajni Sinha, Kevin C. Ward, Otis W. Brawley, Joseph Lipscomb & Christopher R. Flowers. (2010) Racial differences in the presentation and outcomes of diffuse large B‐cell lymphoma in the United States. Cancer 117:11, pages 2530-2540.
Crossref
Crossref
Dennis D. WeisenburgerKerry J. SavageNancy Lee HarrisRandy D. GascoyneElaine S. JaffeKenneth A. MacLennanThomas RüdigerStefano PileriShigeo NakamuraBharat NathwaniElias CampoFrancoise BergerBertrand CoiffierWon-Seog KimHarald HolteMassimo FedericoWing Y. AuKensei Tobinai, James O. Armitage & Julie M. Vose. (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117:12, pages 3402-3408.
Crossref
Crossref
Francine M. Foss. (2011) Molecular Predictors of Response in Aggressive T-cell Lymphomas. The Cancer Journal 17:2, pages 142-148.
Crossref
Crossref
Tomoaki Akagi, Naoto Takahashi, Kouhei Yamaguchi, Kenichi Ishizawa, Kazunori Murai, Katsushi Tajima, Kazuhiko Ikeda, Yoshihiro Kameoka, Junnichi Kameoka, Shigeki Ito, Yuichi Kato, Hideyoshi Noji, Tsutomu Shichishima, Jugoh Itoh, Ryo Ichinohasama, Hideo Harigae, Yoji Ishida & Kenichi Sawada. (2011) Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum. Journal of Clinical and Experimental Hematopathology 51:1, pages 29-35.
Crossref
Crossref
Pareen Shenoy, Alison Maggioncalda, Neha Malik & Christopher R. Flowers. (2011) Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United States. Advances in Hematology 2011, pages 1-11.
Crossref
Crossref
BS Wilkins. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
419
449
.
Matthew Howard & Ahmet Dogan. (2010) Diagnosis of Nodal Peripheral T-Cell Lymphomas. Surgical Pathology Clinics 3:4, pages 955-988.
Crossref
Crossref
Ahmet Dogan & Andrew Feldman. (2010) T- and NK-cell lymphoma update. Diagnostic Histopathology 16:2, pages 99-110.
Crossref
Crossref
Dagmar von Bubnoff. 2010. Natural Killer Cells. Natural Killer Cells
255
266
.
Dan Jones. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology
391
412
.
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2009. Bone Marrow Pathology. Bone Marrow Pathology
300
420
.
Taoying HuangPareen J. ShenoyRajni SinhaMichael GraiserKevin W. BumpersChristopher R. Flowers. (2009)
Development of the Lymphoma Enterprise Architecture Database: A caBIG
™
Silver Level Compliant System
. Cancer Informatics 8, pages CIN.S940.
Crossref
Crossref